AXON Neuroscience is a biotech company dedicated to the development of disease modifying immunotherapy and early diagnostics for Alzheimer's disease.Ground-breaking discoveries in Alzheimer’s disease research made by AXON Neuroscience enabled the company to create a therapeutic platform of global importance. The target products of strategical importance in this platform are revolutionary therapeutic candidate vaccines for treatment of Alzheimer's disease.AXON Neuroscience has developed unique animal models that reproduce Alzheimer’s disease, which allow for a swift and effective pre-clinical validation of efficacy of new therapeutics and pre-clinical evaluation of diagnostic tools.Strategically targeted research and development provides AXON Neuroscience with conditions for future production of an extensive assortment of disease modifying pharmaceuticals and diagnostic methods for Alzheimer’s disease.

Publications show all

AXON Neuroscience has published 18 articles.

Patents show all

24Applications15Issued

Clinical Trials show all

3Phase 11Phase 2